CAS 1391385-57-1

Fórmula: C17H19ClN2O3

InChI: InChI=1S/C17H19ClN2O3/c18-13-5-3-4-12(10-13)8-9-19-15(21)11-16(22)20(17(19)23)14-6-1-2-7-14/h3-5,10,14H,1-2,6-9,11H2

Chave InChI: AJKSBVCOTKODMF-UHFFFAOYSA-N

SMILES: C1CCC(C1)N2C(=O)CC(=O)N(C2=O)CCC3=CC(=CC=C3)Cl

CaV1.3 antagonist-1

CAS: 1391385-57-1

CaV1.3 antagonist-1

Fórmula: C₁₇H₁₉ClN₂O₃

Pureza: ≥95%

Peso molecular: 334.8

Ref: 54-OR1131952

CaV1.3 antagonist-1

CAS: 1391385-57-1

Pureza: 98%

Ref: IN-DA024B4M

1-(3-Chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione

CAS: 1391385-57-1

1-(3-Chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione is a novel ion channel activator that binds to the ligand site of the human ether-a-go-go related gene potassium channel. It has been shown to inhibit the activity of voltage gated sodium channels and calcium activated potassium channels with IC50 values in the low nanomolar range. It has also been shown to be an effective inhibitor of protein binding.

Fórmula: C₁₇H₁₉ClN₂O₃

Pureza: Min. 95%

Peso molecular: 334.8 g/mol

Ref: 3D-RFC38557

CaV1.3 antagonist-1

CAS: 1391385-57-1

CaV1.3 antagonist-1 is a selective CaV1.3L-type calcium channel antagonist useful for researching neurological disorders and cardiovascular diseases.

Fórmula: C₁₇H₁₉ClN₂O₃

Cor e Forma: Solid

Peso molecular: 334.8

Ref: TM-T61026